|
|
Volumn 361, Issue 8, 2009, Pages 818-820
|
|
Increasing options for the treatment of osteoporosis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
DENOSUMAB;
ESTROGEN;
IBANDRONIC ACID;
OSTEOCLAST DIFFERENTIATION FACTOR;
PARATHYROID HORMONE[1-34];
RALOXIFENE;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;
RISEDRONIC ACID;
ZOLEDRONIC ACID;
ANDROGEN DEPRIVATION THERAPY;
BONE DENSITY;
BONE MINERALIZATION;
BONE NECROSIS;
BONE REMODELING;
BONE TURNOVER;
CELL SURVIVAL;
CELLULITIS;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
ECZEMA;
EDITORIAL;
FEMUR FRACTURE;
FEMUR SUBTROCHANTERIC FRACTURE;
FOOD AND DRUG ADMINISTRATION;
HIP FRACTURE;
HUMAN;
IMMUNE SYSTEM;
INFECTION;
JAW OSTEONECROSIS;
KIDNEY;
KIDNEY FAILURE;
NEOPLASM;
OSSIFICATION;
OSTEOCLAST;
OSTEOLYSIS;
OSTEOPOROSIS;
PATIENT COMPLIANCE;
POSTMENOPAUSE;
PRIORITY JOURNAL;
PROSTATE CANCER;
RISK REDUCTION;
TREATMENT CONTRAINDICATION;
VERTEBRA FRACTURE;
|
|
EID: 69049100051
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe0905480 Document Type: Editorial |
|
Times cited : (71)
|
|
References (1)
|
